Venture Life Group (VLG) Capital Markets Day - 6th June 2023

Venture Life Group plc, a leader in developing, manufacturing and commercialising products for the international self-care market, hosted a capital markets event for analysts and investors, on 6 June 2023, senior executives, operational management and product champions presented. Paul McGreevy, Non-Executive Chair00:16 - Introduction Jerry Randall, CEO01:50 - Introduction04:36 - Business overview Daniel Wells, CFO09:36 - Financial Overview Jerry Randall, CEO25:08 - Key brands25:46 - Introduction to Balance Activ Dr Shazia Malik, MBChB31:42 - About BV44:25 - Why recommend Balance Activ?46:58 - Womens health trends Jerry Randall, CEO50:47 - Introduction to Lift Vanessa Haydock54:27 - About Diabetes59:26 - Lift user experience01:01:29 - The science behind Lift1:03:33- The wider market for Lift Jerry Randall, CEO01:05:31 - Introduction to Earol Hillary Harkin01:10:15 - About Ear wax buildup01:18:37 - Why recommend Earol?01:21:12 - Growth opportunities for Earol Lorenzo Morini, Commercial director01:23:14 - UK Distribution Natalia Ocio Mellid, Director of International Brands01:33:00 - International Distribution Jocelyn Kirby, Head of E-Commerce01:42:25 - E-Commerce Gianluca Braguti, Chief Manufacturing/Operations Officer01:52:42 - Group CDMO Introduction Stefania Abbattista, Head of R&D02:07:05 - Development Capability/NPD Domenico Barbaro, Purchasing & Supply Chain Group Director02:15:34 - Supply Chain Marco Castelnovo, Head of Private International Label & Contract Manufacturing02:26:12 - Customer Brands Jerry Randall, CEO02:34:20 - Conclusion 02:35:57 - Q&A Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in the UK, Italy, The Netherlands and Sweden, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, the Balance Activ range in the area of women's intimate healthcare, the Lift and Glucogel product ranges for hypoglycaemia, Gelclair and Pomi-T for oncology support, products for fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing. Its products are sold in over 90 countries worldwide. The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples. In the UK and The Netherlands these are supplied direct by the company to retailers, elsewhere they are supplied by the Group's international distribution partners. Through its two Development & Manufacturing operations in Italy and Sweden, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.